[Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].

Klin Med (Mosk)

Department of Therapy, Faculty of Advanced Training for Doctors, MONIKI of MV Vladimirskii.

Published: March 1997

Download full-text PDF

Source

Publication Analysis

Top Keywords

[peculiarities cardiac
4
cardiac failure
4
failure treatment
4
treatment diffuse
4
diffuse myocarditis
4
myocarditis dilated
4
dilated cardiomyopathy]
4
[peculiarities
1
failure
1
treatment
1

Similar Publications

The topic of the timing of the manifestation of age-associated diseases (as an indirect indicator of accelerated population aging) after the transfer of COVID-19 remains an urgent area in scientific research. Early targeted diagnosis can significantly reduce the consequences of pathology, in connection with which the features of the manifestation of various nosologies in the post-COVID period were studied. The materials were the accounting and statistical data of the municipal polyclinics of the Sakhalin Region for the pre-COVID (2017-2019) and post-COVID (2022-2023) periods.

View Article and Find Full Text PDF

[An unusual tricuspid regurgitation].

G Ital Cardiol (Rome)

January 2025

U.O. Cardiologia, Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica, Università degli Studi, Brescia.

Tricuspid regurgitation can be due to different causes and mechanisms. Among these, cardiac involvement in carcinoid disease is a rare cause of tricuspid valve disease with a peculiar echocardiographic aspect. We report the case of a 59-year-old woman, with no past medical history, who was recently found to have a heart murmur and signs of right heart failure.

View Article and Find Full Text PDF

Mineralocorticoid receptor antagonists (MRAs) represent one of the cornerstones of treatment for heart failure with reduced ejection fraction. Post-hoc data from the TOPCAT trial, conducted in patients with heart failure mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), suggest the possible clinical benefit of MRAs, particularly for slightly reduced ejection fraction values. The advent of non-steroidal MRAs, including finerenone, seems to represent a turning point in the treatment for HFmrEF/HFpEF.

View Article and Find Full Text PDF

During an ECG-training course, a case of extreme respiratory sinus arrhythmia (RSA) was found in a 19-year-old slender, female student who was not active in sports. The heart rate (HR) fluctuated from above 100 to below 60 beats per minute (bpm), often from one beat to the next. The pattern was repetitive and appeared to be linked to respiration, representing an extreme form of RSA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!